Global Interventional Oncology Market 2025-2029

Interventional Oncology Market 2025-2029

The interventional oncology market is forecasted to grow by USD 1663.4 mn during 2024-2029, accelerating at a CAGR of 9% during the forecast period. The report on the interventional oncology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase prevalence of cancer, growing demand for minimally invasive surgical procedures, and growing focus on research and development activities in interventional oncology.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's interventional oncology market is segmented as below:

By End-user

• Hospitals and diagnostic centers
• Ambulatory surgery centers
• Research and academic institutes

By Product

• Particle embolization
• Ablation
• Support devices

By Disease Type

• Liver cancer
• Lung cancer
• Kidney cancer
• Bone metastases
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing focus on the adoption of mwa as one of the prime reasons driving the interventional oncology market growth during the next few years. Also, growing adoption of sirt and hifu and increasing inorganic growth strategies by companies will lead to sizable demand in the market.

The report on the interventional oncology market covers the following areas:

• Interventional Oncology Market sizing
• Interventional Oncology Market forecast
• Interventional Oncology Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading interventional oncology market vendors that include AngioDynamics Inc., Becton Dickinson and Co., Boston Scientific Corp., Cook Group Inc., Elekta AB, HealthTronics Inc., Hologic Inc., IceCure Medical Ltd., INSIGHTEC Ltd., Johnson and Johnson, Medtronic Plc, MedWaves Inc., Merit Medical Systems Inc., Mermaid Medical Group, Profound Medical Corp., Quantum Surgical SAS, Siemens AG, Sirtex Medical Pty Ltd., Teleflex Inc., and Terumo Corp.. Also, the interventional oncology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.